Vertex Pharmaceuticals Incorporated
Boston, MA Doing business as Vertex Pharmaceuticals Incorporated
- UEI
- Y4NLRU471XL7
- CAGE
- 4LQG8
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 50 Northern Ave, Boston, MA 02210, USA
- Website
- vrtx.com
- Founded
- 1989
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase 2 study of VX-770 in cystic fibrosis subjectswith G551D | Food and Drug Administration | $350,000 | |
| Identification of novel immunosuppresive agents | National Institutes of Health | $182,158 |
Contract vehicles
Quick answers
What is Vertex Pharmaceuticals Incorporated's UEI?
Vertex Pharmaceuticals Incorporated's Unique Entity ID (UEI) in SAM.gov is Y4NLRU471XL7.
What is Vertex Pharmaceuticals Incorporated's CAGE code?
Vertex Pharmaceuticals Incorporated's CAGE code is 4LQG8.
What is Vertex Pharmaceuticals Incorporated's primary NAICS code?
Vertex Pharmaceuticals Incorporated's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Vertex Pharmaceuticals Incorporated located?
Vertex Pharmaceuticals Incorporated's physical address in SAM.gov is 50 Northern Ave, Boston, MA 02210, USA.
Is Vertex Pharmaceuticals Incorporated registered in SAM.gov?
Yes. Vertex Pharmaceuticals Incorporated's SAM.gov registration is active through December 17, 2026.
Which contract vehicles does Vertex Pharmaceuticals Incorporated hold?
Vertex Pharmaceuticals Incorporated holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Vertex Pharmaceuticals Incorporated's most recent federal award?
Vertex Pharmaceuticals Incorporated's most recent federal grant award is Phase 2 study of VX-770 in cystic fibrosis subjectswith G551D (R01FD003432), from Food and Drug Administration, on September 30, 2007.
On GovTribe
See Vertex Pharmaceuticals Incorporated's full federal record
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors